Dr Agarwal's Eye

  • Market Cap: Small Cap
  • Industry: Hospital
  • ISIN: INE934C01018
  • NSEID:
  • BSEID: 526783
INR
5,500.00
3.05 (0.06%)
BSENSE

Dec 05

BSE+NSE Vol: 598

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Dr Agarwals Eye Hospital Ltd stock-summary
stock-summary
Dr Agarwals Eye Hospital Ltd
Small Cap
Hospital
Founded in 1957, Dr. Agarwal's Eye Hospital Limited was incorporated on April 22, 1994. The Hospital is a leading chain of eye hospitals with predominant presence in Tamil Nadu. Company has been a pioneer and leader into the Indian Ophthalmology market in the eye care division. It offers comprehensive services in the eye-care segment including Cataract, Glaucoma, Laser Correction, Cornea and Refractive, Retina, and Squint among others. It has presence in Tamil Nadu, Kerala and Rajasthan states.
Company Coordinates stock-summary
Company Details
3rd Floor Buhari Tower No 4, Moores Road Off Greams Road Chennai Tamil Nadu : 600006
stock-summary
Tel: 91-44-39916600
stock-summary
investor@dragarwal.com
Registrar Details
Integrated Enterprises (India) Ltd , II Floor , Kences Towers, No 1 Ramakrishna Street, North Usman Road, T Nagar, Chennai
stock-summary Capital Structure
Capital Structure stock-summary
Present Equity Capital
INR 4.70 Cr
Number of Shares
47 Cr
Face Value
INR 10.0
Date
Number
of Shares(Cr)
Equity
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
05-Aug-2013
47
4.70
200000
10
ESOP
05-Aug-2013
47
4.70
200000
10
ESOP
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

29.2618

Mutual Funds

Held by 4 Schemes (0.18%)

FIIs

Held by 3 FIIs (1.74%)

Promoter with highest holding

Dr Agarwals Health Care Limited (72.67%)

Highest Public shareholder

Varun Ashok Hiremath (2.07%)

Individual Investors Holdings

18.17%

stock-summary Board of Directorsstock-summary
stock-summary
Management
Designation
Remuneration
Amar Agarwal.
Chairman / Executive Director
2.36 cr
Athiya Agarwal
WTD & Executive Director
92.0 lacs
Sanjay Anand
Independent Non Exe. Director
1.0 lacs
Adil Agarwal
Non Executive Director
0
Lakshmmi Subramanian
Independent Non Exe. Director
1.0 lacs
V Balakrishnan
Independent Non Exe. Director
1.0 lacs
stock-recommendationRaw Materials
Raw Materials Dashboard stock-summary
Raw Materials
Amount(Rs Cr)
% of RM Cost
Pharmaceutical Products
18.49
0%
 
100
Pharmaceutical Products
stock-recommendation Finished Goods
Finished Goods Dashboard stock-summary
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
Other Operating Revenues - Research Support Services
0.65
0.38%
 
0.38
Other Operating Revenues - Research Support Services
99.62
Other Operating Revenues - Research Support Services
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
118 Cr
(Quarterly Results - Sep 2025)
Net Profit:
19 Cr
stock-summary
Industry

Hospital

stock-summary
Market cap

INR 2,651 Cr (Small Cap)

stock-summary
P/E

42.00

stock-summary
Industry P/E

63

stock-summary
Dividend Yield

0.12%

stock-summary
Debt Equity

0.77

stock-summary
Return on Equity

20.02%

stock-summary
Price to Book

8.37